Etanercept and adalimumab in patients with RA and SpA in clinical practice: adverse events and other reasons leading to discontinuation of the treatment
- T Läkinenpi (Contributor)
- M Korpela (Contributor)
- Vuolteenaho, K. (Contributor)
- E Moilanen (Contributor)
Activity: Talk or presentation › Conference presentation